# MOVANTIK

NDC: 57841-1301
Generic name: naloxegol oxalate
Labeler / Manufacturer: RedHill Biopharma Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20201001
Marketing ended: 20270131
FDA application: NDA204760

## Active ingredients

- NALOXEGOL OXALATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57841-1301"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57841-1301
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=300a6474-ebcd-4404-8040-48fdcfcc1635